A pharmaceutical company from Turkey, selling finished product of Quercetin complex and dossiers. Manufacturing site is TurkeyQuercetin complex includes the important bioflavonoid quercetin in a synergistic formula with vitamin C and bromelain to provide unique antioxidant protection as well as natural seasonal support. Has antioxidant properties which help to stabilize cell membranes. Offers the additional benefits of incorporating acerola...

A pharmaceutical company from Turkey, selling finished product of Standardized Black Elderberry Extract, Beta Glucan (Yeast), Zinc and Vitamin C syrup. Effective OTC product for  immune system empwerment.   Manufacturing site is TurkeySyrup contains a synergestic formulation; 25 mg Black Elderberry Extract 50 mg Beta Glucan 5 mg Zinc 80 mg Vitamin CProduct help to support the immune systemFinished product specification is 150...

Member of Farmavita.Net offer Faviravir Dossier with supply: Favipravir 200 mg tablet (40 tablet / box) API source: DMF (China or India) / GMP facility Finished dose facility: Turkey / EU GMP First marketing authorisation: Turkey Dossier: EU CTD with supply agreeement                

Sildenafil 100 mg gel, patented formulation.  1 box: 4 sachet x 5gr API source: CEP(İndia) / GMP facility Finished dose facility: Turkey / EU GMP First marketing authorisation: Turkey Dossier: EU CTD with supply agreeement

We offer a dossier for registration of Tacrolimus in capsules of 3 doses.       Tacrolimus 0.5 mg capsule Tacrolimus 1 mg capsule Tacrolimus 5mg capsule Number of Pages     Number of Pages Number of Pages Number of Pages Number of Pages CTD        2.854       2.850       2.850      8.554   M1   45 45 45       135   M2                 -       2.1. 5 5 5        ...

Active substance formulated into Tivortin®  – L-arginine amino acid — is the only substrate for nitric oxide (NO) synthesis in humans. Tivortin® aspartate is a potent vasodilator, vascular tone regulator.   Tivortin® aspartate is a universal angioprotector:  ♦ reduces activation and adhesion of leukocytes to the endothelium; ♦ has antithrombotic properties, reduces platelets adhesion, their activation and aggregation;  ♦ prevents...

1. An entirely new combination. An original analgesic, which is not a scheduled drug. 2. The combination is in complete compliance with a global trend of multimodal analgesia.  3.  The option for adequate pain control (equivalent to morphine) achieved with low doses and with minimal complications and adverse effects.   The conditions for licensing-out selling of the product. 1. Documents to be transferred:   -     Pharmaceutical...

Normal 0 false false false EN-US X-NONE HE /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-parent:""; mso-padding-alt:0cm 5.4pt 0cm 5.4pt; mso-para-margin:0cm; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:10.0pt; font-family:"Times New Roman",serif; mso-bidi-language:HE;}...

Infliximab API available: - from EU cGMP certified facility  - exceptional quality  - fill-finish possibilities Please ask for more info.

I’m a representative of Parafarm (Penza, Russia) for foreign relations. We propose unique products for osteoporosis and arthritis treatment on the basis of beekeeping product, drone brood. Some information in English you can find here: https://osteomed.su/category/english/ Some other products on the basis of beekeeping products are offered too. We have got some patents, including WO, EP, US, for our products. But information in English...

Member of Farmavita.net is offering dossier in European CTD format for Ibuprofen, 600 mg, sachets. Dossier is submitted in reference member state. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions....

There is on-going development of  generic EU CTD Dossier of  Escitalopram, tablets. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights.

Farmavita.Net members, from India,  are offering  license-out  of formulation documentation for more than two hundred (200)  pharmaceutical products. Each CTDossier is available for lump sum payment, without supply obligation. This Dossiers does not include  clincal studies.   Click Here to download the complete list of available formulations, with example of Dossier Table of Contents, for one product.  It is expected that buyer of...

Member of Farmavita.net is offering dossier in European CTD format for Anastrazole, 1 mg, tablets. Dossier is authorised in EU. Masrting authorisation transfer is available.  License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Anastrazole  is classified as  antineoplastic medicine,  according ATC index. Offer is valid subject to confirmation, country by country. Development of this...

Farmavita.Net member has developed technology which enables development of oral dosage forms with  controlled and site specific release of active pharmaceutical ingredients. Patent pending application.   Company is looking for following types of cooperation: - Out-licensing - Joint-venture and private equity partners - Collaborative product development - Consulting or contract research contracts Description of technology: - the...

License-out offer for 6-APA API technology                                              Member of Farmavita.net offers know-how for fermentation process for manufacture of active pharmaceutical ingredient of 6 APA. Know how is available as non-exclusive license with lump sum payment. Payment is made after yield and quality of API is confirmed in the laboratory. Guarantied process parameters are:   6-APA Intermediate 6-AMINOPENICILLANIC...

Member of Farmavita.net is offering dossier in European CTD format forZopiclone, 3,75/7,5 mg; tablets.   Dossier is registered in The Netherlands. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.     Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with...

There is on-going development of generic EU CTD Dossier of Zolmitriptan, tablets and mouth dissolving tablets, 2.5/5 mg. DCP slot confirmed. Development of this pharmaceutical is carried out according to EU-requirements in country without patent protection or with Bolar-provisions. There will be no sales in those countries where this offer would constitute an infringement of third parties intellectual proprietary rights. Zolmitriptan is a...

Member of Farmavita.net is offering dossier in European CTD format for Zeledronic acid, 4 mg, lyophilized powder for injection. Dossier is under development. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Zeledronic acid is classified as an antineoplastic, according ATC index. Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is carried out...

Member of Farmavita.net is offering dossier in European CTD format for Vinorelbine, 10 mg/ml as 10 – 50 mg solution, solution for injection. Dossier is ready, not submitted. License for use of Dossier is related to initial downpayment and commitment to bulk purchase.   Vinorelbine is classified as an antineoplastic, according ATC index. Offer is valid subject to confirmation, country by country. Development of this pharmaceutical is...